CARL ZEISS MEDITEC’S NEAR-TERM OUTLOOK DIMS (SELL; 11% DOWNSIDE)
16/11/20 -"At the start of 2020, Carl Zeiss Meditec/CZM (Sell, Germany) was trading at its life-time high levels as the FY 18/19 (ending September 2019) sales growth and operating margin hit record highs – ..."
Pages
60
Language
English
Published on
16/11/20
You may also be interested by these reports :
25/02/26
Fresenius delivered solid Q4 25 results, supported by broad-based growth across Kabi and Helios. Biopharma remained the key growth engine, supported ...
24/02/26
FMC delivered a strong Q4 profit beat, with record profitability driven by accelerated FME25+ savings and operational discipline. FY 25 results also ...
23/02/26
Considering the lower medium-to-long-term expectations, the premium for peer-based metrics has been reduced to 25% (vs. 50% previously). However, ...
20/02/26
Since we began coverage on Elekta (BUY; Sweden) in January 2020, medical equipment and software provider for cancer treatment using radiation ...